Fisher & Paykel Healthcare (FPH) Stock Price, News & Analysis

Company Overview

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 575,466 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 1.17%
• Price Target: N/A
• Consensus Rating: N/A

FPH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Fisher & Paykel Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Fisher & Paykel Healthcare investors own include ResMed (RMD), CSL (CSL), Mineral Resources (MIN), NVIDIA (NVDA), Accent Group (AX1), Cochlear (COH) and Corporate Travel Management (CTD).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Real Estate
• Current Symbol: ASX:FPH
• CUSIP: N/A
• CIK: N/A
• Web: www.fphcare.com
• Phone: +64-9-5740100
• Fax: N/A
• Employees: 100
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A$0.21
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 4.47
• Net Income: $132.60 million
• Net Margins: 7.61%
• Pretax Margin: N/A
• Return on Equity: 7.55%
• Return on Assets: 9.85%

Debt

• Debt-to-Equity Ratio: 10.75
• Current Ratio: 1.83
• Quick Ratio: 0.79

Sales & Book Value

• Annual Sales: $1.74 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 99.62
• Book Value: A$3.02 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 583,980,000
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.42